Celgene Profits Rise

Make a comment

In a statement, ceo Sol Barer crowed that the results were “outstanding.”

Net income rose to $22.9 million, or 6 cents a share, from $3.9 million, or 1 cent a share, a year earlier. Excluding one-time items, the company earned 18 cents a share.

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/